Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry.
Share this article
Corporate
Score 45
Neutral
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry
Mar 28, 2026 20:51 UTC
BMY, XLV, IHF
Short term
Related Articles
Score 65
Bullish
Telefonica AGM OKs All Board Proposals, Confirms €0.15 Dividend and Transformation Strategy
Mar 28, 23:02
Score 65
Bullish
SpaceX And Anthropic IPO Frenzy Begins Early As REX Shares, Tuttle Capital File For 2x Leveraged ETFs
Mar 28, 22:31
Score 78
Bearish
Oracle stock dividend under threat amid massive AI push
Mar 28, 22:07
Score 25
Bearish
Jim Cramer Provides the “Bear Case” for Paychex, Inc. (PAYX)
Mar 28, 21:15
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.